Born in Mumbai, Reshma moved to the United States at the age of 11. She earned her medical degree from Boston University and ...

Some Boston public school students are spending their summer vacations learning and working at a global biotech company.

Frazier was among the most active venture investors in 2024, according to analysts at William Blair, backing 17 private life ...

The consumer discretionary sector is top-heavy. At the end of 2024, Amzon.com Inc. (AMZN) made up 37% of the sector's market cap, while Tesla made up 21%. Amazon's stock was up 5% for 2025 through ...

Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS XII), with over $1.3 billion in ...

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggested big pharma may finally be willing to place ...

An economist told Newsweek that President Trump's widespread tariffs have put sectors of the economy in a wait-and-see ...

On July 31, 2025, Vertex Pharmaceuticals (VRTX) witnessed a significant trading volume jump, reaching $680 million, a 46.13% spike from the day before. This volume surge ranked VRTX 194th in trading ...

Thursday closed down -0.37%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.74%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.55%. September E-mini S&P futures (ESU25) fell ...

Last week, Australian life sciences venture capital firm Brandon Capital closed its largest fund yet, raising A$439 million ...

Gene Therapy Market Gene therapy market surges on breakthroughs in genome editing, rising chronic & genetic disease cases, regulatory appro ...

Regeneron Pharmaceuticals (REGN) is gearing up for an earnings announcement that could pivot its stock's current trajectory.